kneat.com, inc. announced it has signed a three-year Master Services Agreement with a global healthcare leader whose product portfolio spans multiple therapeutic divisions from medical devices through to pharmaceuticals. The Agreement is effective immediately and allows the company to scale Kneat to all validation processes across all these business divisions. Kneat was selected after extensive evaluations of market options for both computer systems validation and equipment validation.

Of the three business divisions that will initially be deploying Kneat Gx, one is replacing a paper-intensive process while the others are upgrading their current approach from hybrid to fully digital. The Agreement positions Kneat well for later expansion within the company, which has over 100,000 employees and more than 80 manufacturing sites worldwide. Implementation will commence in First Quarter 2023, with an initial go-live date in Second Quarter 2023.